# A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis

> **NCT05195814** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 141 (actual)

## Conditions studied

- Psoriatic Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05195814
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-15
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2025-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05195814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05195814, "A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT05195814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*